216 related articles for article (PubMed ID: 27231154)
1. Tolerance to the Diuretic Effects of Cannabinoids and Cross-Tolerance to a κ-Opioid Agonist in THC-Treated Mice.
Chopda GR; Parge V; Thakur GA; Gatley SJ; Makriyannis A; Paronis CA
J Pharmacol Exp Ther; 2016 Aug; 358(2):334-41. PubMed ID: 27231154
[TBL] [Abstract][Full Text] [Related]
2. Diuretic effects of cannabinoids.
Paronis CA; Thakur GA; Bajaj S; Nikas SP; Vemuri VK; Makriyannis A; Bergman J
J Pharmacol Exp Ther; 2013 Jan; 344(1):8-14. PubMed ID: 23019138
[TBL] [Abstract][Full Text] [Related]
3. Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ
Ford BM; Cabanlong CV; Tai S; Franks LN; Penthala NR; Crooks PA; Prather PL; Fantegrossi WE
J Pharmacol Exp Ther; 2019 May; 369(2):259-269. PubMed ID: 30833484
[TBL] [Abstract][Full Text] [Related]
4. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
Welch SP; Dunlow LD; Patrick GS; Razdan RK
J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligodeoxynucleotides to the kappa1 receptor enhance delta9-THC-induced antinociceptive tolerance.
Rowen DW; Embrey JP; Moore CH; Welch SP
Pharmacol Biochem Behav; 1998 Feb; 59(2):399-404. PubMed ID: 9476987
[TBL] [Abstract][Full Text] [Related]
6. Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.
Gerak LR; France CP
J Pharmacol Exp Ther; 2016 May; 357(2):357-66. PubMed ID: 26937020
[TBL] [Abstract][Full Text] [Related]
7. Diuretic effects of cannabinoid agonists in mice.
Chopda GR; Vemuri VK; Sharma R; Thakur GA; Makriyannis A; Paronis CA
Eur J Pharmacol; 2013 Dec; 721(1-3):64-9. PubMed ID: 24099963
[TBL] [Abstract][Full Text] [Related]
8. Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.
Welch SP
J Pharmacol Exp Ther; 1993 May; 265(2):633-40. PubMed ID: 8388455
[TBL] [Abstract][Full Text] [Related]
9. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
10. A high efficacy cannabinergic ligand (AM4054) used as a discriminative stimulus: Generalization to other adamantyl analogs and Δ(9)-THC in rats.
Järbe TU; LeMay BJ; Thakur GA; Makriyannis A
Pharmacol Biochem Behav; 2016 Sep; 148():46-52. PubMed ID: 27264437
[TBL] [Abstract][Full Text] [Related]
11. Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys.
Gerak LR; Zanettini C; Koek W; France CP
Psychopharmacology (Berl); 2015 Oct; 232(19):3637-47. PubMed ID: 26202613
[TBL] [Abstract][Full Text] [Related]
12. Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.
Smith PB; Welch SP; Martin BR
J Pharmacol Exp Ther; 1994 Mar; 268(3):1381-7. PubMed ID: 8138952
[TBL] [Abstract][Full Text] [Related]
13. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.
Ghozland S; Matthes HW; Simonin F; Filliol D; Kieffer BL; Maldonado R
J Neurosci; 2002 Feb; 22(3):1146-54. PubMed ID: 11826143
[TBL] [Abstract][Full Text] [Related]
14. Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.
Tai S; Hyatt WS; Gu C; Franks LN; Vasiljevik T; Brents LK; Prather PL; Fantegrossi WE
Pharmacol Res; 2015 Dec; 102():22-32. PubMed ID: 26361728
[TBL] [Abstract][Full Text] [Related]
15. Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys.
Hruba L; Ginsburg BC; McMahon LR
J Pharmacol Exp Ther; 2012 Sep; 342(3):843-9. PubMed ID: 22718500
[TBL] [Abstract][Full Text] [Related]
16. Comparative diuretic activity of delta9-tetrahydrocannabinol, cannabidiol, cannabinol and hydrochlorothiazide in the rat.
Sofia RD; Knobloch LC; Harakal JJ; Erikson DJ
Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):77-87. PubMed ID: 849066
[TBL] [Abstract][Full Text] [Related]
17. Long-Lasting In Vivo Effects of the Cannabinoid CB1 Antagonist AM6538.
Paronis CA; Chopda GR; Vemuri K; Zakarian AS; Makriyannis A; Bergman J
J Pharmacol Exp Ther; 2018 Mar; 364(3):485-493. PubMed ID: 29311110
[TBL] [Abstract][Full Text] [Related]
18. Alterations in murine delayed type hypersensitivity responses by delta-8-THC and cannabinol.
Levy JA; Heppner GH
J Immunopharmacol; 1978-1979; 1(1):105-14. PubMed ID: 233841
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in acute delta-9-tetrahydrocannabinol (Δ
Lulek CF; Maulik M; Mitra S; Guindon J; Morgan DJ; Henderson-Redmond AN
Psychopharmacology (Berl); 2023 Sep; 240(9):1987-2003. PubMed ID: 37516707
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol modulation of antinociceptive tolerance to Δ
Greene NZ; Wiley JL; Yu Z; Clowers BH; Craft RM
Psychopharmacology (Berl); 2018 Nov; 235(11):3289-3302. PubMed ID: 30238130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
